CD147: A novel modulator of inflammatory and immune disorders

Current Medicinal Chemistry

Volumn 21, Issue 19, 2014, Pages 2138-2145

  Zhu, X ^a   Song, Z ^c   Zhang, S ^a   Nanda, A ^a   Li, G ^a,b  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CD147; Cyclophilin; Inflammation; Integrin; Leukocyte; MCT; MMP; Platelet

Indexed keywords

CAVEOLIN 1; CD147 ANTIGEN; CYCLOPHILIN; INTEGRIN; MONOCARBOXYLATE TRANSPORTER;

ALLERGIC ASTHMA; ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MEMBRANE; DISEASE SEVERITY; ENDOTHELIUM CELL; HEART INFARCTION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; ISCHEMIA; LEUKOCYTE; LUNG INJURY; MULTIPLE SCLEROSIS; NEUTROPHIL; PNEUMONIA; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; THROMBOCYTE ACTIVATION; VIRUS HEPATITIS; ANIMAL; CHEMISTRY; HUMAN; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD147; HUMANS; IMMUNE SYSTEM DISEASES; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTES;

EID: 84899867704     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867321666131227163352     Document Type: Article

References (60)

1. Brasier, A.R. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc. Res., 2010, 86(2), 211-218.
2. Hansson, G.K. Inflammatory mechanisms in atherosclerosis. J. Thromb. Haemost., 2009, 7 Suppl 1, 328-331.
3. Conductier, G.; Blondeau, N.; Guyon, A.; Nahon, J.L.; Rovère, C. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J. Neuroimmunol., 2010, 224(1-2), 93-100.
4. Agrawal, S.M.; Yong, V.W. The many faces of EMMPRIN - roles in neuroinflammation. Biochim. Biophys. Acta., 2011, 1812(2), 213-219.
5. Kessenbrock, K.; Plaks, V.; Werb, Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell, 2010, 141(1), 52-67.
6. Schmidt, R.; Bültmann, A.; Fischel, S.; Gillitzer, A.; Cullen, P.; Walch, A.; Jost, P.; Ungerer, M.; Tolley, ND.; Lindemann, S.; Gawaz, M.; Schömig, A.; May, A.E. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes. Circ. Res., 2008, 102(3), 302-309.
7. Gwinn, W.M.; Damsker, J.M.; Falahati, R.; Okwumabua, I.; Kelly-Welch, A.; Keegan, A.D.; Vanpouille, C.; Lee, J.J.; Dent, L.A.; Leitenberg, D.; Bukrinsky, M.I.; Constant, S.L. Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. J. Immunol., 2006, 177(7), 4870-4879.
8. Arora, K.; Gwinn, W.M.; Bower, M.A.; Watson, A.; Okwumabua, I.; MacDonald, H.R.; Bukrinsky, M.I.; Constant, S.L. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J. Immunol., 2005, 175(1), 517-522.
9. Tian, X.; Zhao, C.; Zhu, H.; She, W.; Zhang, J.; Liu, J.; Li, L.; Zheng, S.; Wen, Y.M.; Xie, Y. Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection. J. Virol., 2010, 84(7), 3373-3381.
10. Zhu, P.; Lu, N.; Shi, Z.G.; Zhou, J.; Wu, Z.B.; Yang, Y.; Ding, J.; Chen, Z.N. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes. Arthritis. Res. Ther., 2006, 8(2), R44.
11. Schmidt, R.; Bültmann, A.; Ungerer, M.; Joghetaei, N.; Bülbül, O.; Thieme, S.; Chavakis, T.; Toole, B.P.; Gawaz, M.; Schömig, A.; May, A.E. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction. Circulation, 2006, 113(6), 834-841.
12. Burggraf, D.; Liebetrau, M.; Martens, H.K.; Wunderlich, N.; Jäger, G.; Dichgans, M.; Hamann, G.F. Matrix metalloproteinase induction by EMMPRIN in experimental focal cerebral ischemia. Eur. J. Neurosci., 2005, 22(1), 273-277.
13. Agrawal, S.M.; Silva, C.; Wang, J.; Tong, J.P.; Yong, V.W. A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis. J. Neuroinflammation, 2012, 9, 64.
14. Muramatsu, T.; Miyauchi, T. Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histol. Histopathol., 2003, 18(3), 981-987.
15. Seizer, P.; Schönberger, T.; Schött, M.; Lang, M.R.; Langer, H.F.; Bigalke, B.; Krämer, B.F.; Borst, O.; Daub, K.; Heidenreich, O.; Schmidt, R.; Lindemann, S.; Herouy, Y.; Gawaz, M.; May, A.E. EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation. Atherosclerosis, 2010, 209(1), 51-57.
16. Kasinrerk, W.; Fiebiger, E.; Stefanova, I.; Baumruker, T.; Knapp, W.; Stockinger, H. Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule. J. Immunol., 1992, 149, 847-854.
17. Wang, C.H.; Dai, J.Y.; Wang, L.; Jia, J.F.; Zheng, Z.H.; Ding, J.; Chen, Z.N.; Zhu, P. Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes. J. Cell. Mol. Med., 2011, 15(4), 850-860.
18. Zhu, P.; Ding, J.; Zhou, J.; Dong, W.J.; Fan, C.M.; Chen, Z.N. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production. Arthritis Res. Ther., 2005, 7(5), R1023-1033.
19. Yamani, M.H.; Starling, R.C.; Young, J.B.; Cook, D.; Yu, Y.; Vince, D.G.; McCarthy, P.; Ratliff, N.B. Acute vascular rejection is associated with up-regulation of vitronectin receptor (alphavbeta3), increased expression of tissue factor, and activation of the extracellular matrix metalloproteinase induction system. J. Heart Lung Transplant., 2002, 21(9), 983-989.
20. Haug, C.; Lenz, C.; Díaz, F.; Bachem, M.G. Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase Inducer (EMMPRIN) release by coronary smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 2004, 24(10), 1823-1829.
21. Sun, J.; Hemler, M.E. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res., 2001, 61(5), 2276-2281.
22. Allain, F.; Vanpouille, C.; Carpentier, M.; Slomianny, M.C.; Durieux, S.; Spik, G. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Proc. Natl. Acad. Sci. U S A., 2002, 99(5), 2714-2719.
23. Yurchenko, V.; Pushkarsky, T.; Li, J.H.; Dai, W.W.; Sherry, B.; Bukrinsky, M. Regulation of CD147 cell surface expression: involvement of the proline residue in the CD147 transmembrane domain. J. Biol. Chem., 2005, 280(17), 17013-17019.
24. Yurchenko, V.; Zybarth, G.; O'Connor, M.; Dai, W.W.; Franchin, G.; Hao, T.; Guo, H.; Hung, H.C.; Toole, B.; Gallay, P.; Sherry, B.; Bukrinsky, M. Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J. Biol. Chem., 2002, 277(25), 22959-22965.
25. Kirk, P.; Wilson, M.C.; Heddle, C.; Brown, M.H.; Barclay, A.N.; Halestrap, A.P. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J., 2000, 19(15), 3896-3904.
26. Tang, W.; Hemler, M.E. Caveolin-1 regulates matrix metalloproteinases-1 induction and CD147/EMMPRIN cell surface clustering. J. Biol. Chem., 2004, 279(12), 11112-11118.
27. Tang, Y.; Kesavan, P.; Nakada, M.T.; Yan, L. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol. Cancer Res., 2004, 2(2), 73-80.
28. Berditchevski, F.; Chang, S.; Bodorova, J.; Hemler, M.E. Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/ M6. J. Biol. Chem., 1997, 272(46), 29174-29180.
29. Li, R.; Huang, L.; Guo, H.; Toole, B.P. Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. J. Cell Physiol., 2001, 186(3), 371-379.
30. Sluijter, J.P.; Pulskens, W.P.; Schoneveld, A.H.; Velema, E.; Strijder, C.F.; Moll, F.; de Vries, J.P.; Verheijen, J.; Hanemaaijer, R.; de Kleijn, D.P.; Pasterkamp, G. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. Stroke, 2006, 37(1), 235-239.
31. Lim, M.; Martinez, T.; Jablons, D.; Cameron, R.; Guo, H.; Toole, B.; Li, J.D.; Basbaum, C. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett., 1998, 441(1), 88-92.
32. Taylor, P.M.; Woodfield, R.J.; Hodgkin, M.N.; Pettitt, T.R.; Martin, A.; Kerr, D.J.; Wakelam, M.J. Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A (2) and 5-lipoxygenase catalyzed pathway. Oncogene, 2002, 21(37), 5765-5772.
33. Yuan, W.; Ge, H.; He, B. Pro-inflammatory activities induced by CyPA-EMMPRIN interaction in monocytes. Atherosclerosis, 2010, 213(2), 415-421.
34. Tang, J.; Wu, Y.M.; Zhao, P.; Yang, X.M.; Jiang, J.L.; Chen, Z.N. Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAKPI3K-Ca2+ pathways. Cell Mol. Life Sci., 2008, 65(18), 2933-2942.
35. Dai, J.Y.; Dou, K.F.; Wang, C.H.; Zhao, P.; Lau, W.B.; Tao, L.; Wu, Y.M.; Tang, J.; Jiang, J.L.; Chen, Z.N. The interaction of HAb18G/CD147 with integrin alpha6beta1 and its implications for the invasion potential of human hepatoma cells. BMC. Cance., 2009, 9, 337.
36. Kirsch, A.H.; Diaz, LA Jr.; Bonish, B.; Antony, P.A.; Fox, D.A. The pattern of expression of CD147/neurothelin during human Tcell ontogeny as defined by the monoclonal antibody 8D6. Tissue Antigens, 1997, 50(2), 147-152.
37. Renno, T.; Wilson, A.; Dunkel, C.; Coste, I.; Maisnier-Patin, K.; Benoit de Coignac, A.; Aubry, J.P.; Lees, R.K.; Bonnefoy, J.Y.; MacDonald, H.R.; Gauchat, J.F. A role for CD147 in thymic development. J. Immunol., 2002, 168(10), 4946-4950.
38. Hu, J.; Dang, N.; Yao, H.; Li, Y.; Zhang, H.; Yang, X.; Xu, J.; Bian, H.; Xing, J.; Zhu, P.; Chen, Z. Involvement of HAb18G/CD147 in T cell activation and immunological synapse formation. J. Cell Mol. Med., 2010, 14(8), 2132-2143.
39. Solstad, T.; Bains, S.J.; Landskron, J.; Aandahl, E.M.; Thiede, B.; Taskén, K.; Torgersen, K.M. CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells. Blood, 2011, 118(19), 5141-5151.
40. Stonehouse, T.J.; Woodhead, V.E.; Herridge, P.S.; Ashrafian, H.; George, M.; Chain, B.M.; Katz, D.R. Molecular characterization of U937-dependent T-cell co-stimulation. Immunology, 1999, 96(1), 35-47.
41. Kasinrerk, W.; Tokrasinwit, N.; Phunpae, P. CD147 monoclonal antibodies induce homotypic cell aggregation of monocytic cell line U937 via LFA-1/ICAM-1 pathway. Immunology, 1999, 96(2), 184-192.
42. Ruiz, S.; Castro-Castro, A.; Bustelo, X.R. CD147 inhibits the nuclear factor of activated T-cells by impairing Vav1 and Rac1 downstream signaling. J. Biol. Chem., 2008, 283(9), 5554-5566.
43. Seizer, P.; Ochmann, C.; Schönberger, T.; Zach, S.; Rose, M.; Borst, O.; Klingel, K.; Kandolf, R.; MacDonald, H.R.; Nowak, R.A.; Engelhardt, S.; Lang, F.; Gawaz, M.; May, A.E. Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion. Arterioscler. Thromb. Vasc. Biol., 2011, 31(6), 1377-1386.
44. Kato, N.; Yuzawa, Y.; Kosugi, T.; Hobo, A.; Sato, W.; Miwa, Y.; Sakamoto, K.; Matsuo, S.; Kadomatsu, K. The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia/reperfusion. J. Am. Soc. Nephrol., 2009, 20(7), 1565-1576.
45. Yang, L.X.; Ye, J.S.; Guo, R.W.; Liu, H.; Wang, X.M.; Qi, F.; Guo, C. The effect of the expression of angiotensin II on extracellular matrix metalloproteinase inducer (EMMPRIN) in macrophages is mediated via the AT1/COX-2/PGE2 pathway. Inflamm. Res., 2010, 59(12), 1033-1040.
46. Pennings, G.J.; Yong, A.S.; Kritharides, L. Expression of EMMPRIN (CD147) on circulating platelets in vivo. J. Thromb. Haemost., 2010, 8(3), 472-481.
47. Seizer, P.; Borst, O.; Langer, H.F.; Bültmann, A.; Münch, G.; Herouy, Y.; Stellos, K.; Krämer, B.; Bigalke, B.; Büchele, B.; Bachem, M.G.; Vestweber, D.; Simmet, T.; Gawaz, M.; May, A.E. EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction. Thromb. Haemost., 2009, 101(4), 682-686.
48. Schulz, C.; von Brühl, M.L.; Barocke, V.; Cullen, P.; Mayer, K.; Okrojek, R.; Steinhart, A.; Ahmad, Z.; Kremmer, E.; Nieswandt, B.; Frampton, J.; Massberg, S.; Schmidt, R. EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall. J. Thromb. Haemost., 2011, 9(5), 1007-1019.
49. Agrawal, S.M.; Silva, C.; Tourtellotte, W.W.; Yong, V.W. EMMPRIN: a novel regulator of leukocyte transmigration into the CNS in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Neurosci., 2011, 31(2), 669-677.
50. Zhang, F.; Vannucci, S.J.; Philp, N.J.; Simpson, I.A. Monocarboxylate transporter expression in the spontaneous hypertensive rat: effect of stroke. J. Neurosci. Res., 2005, 79(1-2), 139-145.
51. Han, M.; Trotta, P.; Coleman, C.; Linask, K.K. MCT-4, A511/Basigin and EF5 expression patterns during early chick cardiomyogenesis indicate cardiac cell differentiation occurs in a hypoxic environment. Dev Dyn., 2006, 235(1), 124-131.
52. Seko, Y.; Fujimura, T.; Taka, H.; Mineki, R.; Murayama, K.; Nagai, R. Hypoxia followed by reoxygenation induces secretion of cyclophilin A from cultured rat cardiac myocytes. Biochem. Biophys. Res. Commun., 2004, 317(1), 162-168.
53. Boulos, S.; Meloni, B.P.; Arthur, P.G.; Majda, B.; Bojarski, C.; Knuckey, N.W. Evidence that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury. Neurobiol. Dis., 2007, 25(1), 54-64.
54. Burggraf, D.; Liebetrau, M.; Martens, H.K.; Wunderlich, N.; Jäger, G.; Dichgans, M.; Hamann, G.F. Matrix metalloproteinase induction by EMMPRIN in experimental focal cerebral ischemia. Eur. J. Neurosci., 2005, 22(1), 273-277.
55. Zhu, W.; Khachi, S.; Hao, Q.; Shen, F.; Young, W.L.; Yang, G.Y.; Chen, Y. Upregulation of EMMPRIN after permanent focal cerebral ischemia. Neurochem. Int., 2008, 52(6), 1086-1091.
56. Zhou, S.; Zhou, H.; Walian, P.J.; Jap, B.K. CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production. Proc. Natl. Acad. Sci. USA., 2005, 102(21), 7499-7504.
57. Bamberger, M.E.; Harris, M.E.; McDonald, D.R.; Husemann, J.; Landreth, G.E. A cell surface receptor complex for fibrillar betaamyloid mediates microglial activation. J. Neurosci., 2003, 23(7), 2665-2674.
58. Huang, Z.; Wang, L.; Meng, S.; Wang, Y.; Chen, T.; Wang, C. Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages. Int. J. Cardiol., 2011, 146(2), 153-158.
59. Ge, H.; Zhang, J.F.; Guo, B.S.; He, Q.; Wang, B.Y.; He, B.; Wang, C.Q. Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma. Vascul. Pharmacol., 2007, 46(2), 114-121.
60. Bao, W.; Min, D.; Twigg, S.M.; Shackel, N.A.; Warner, F.J.; Yue, D.K.; McLennan, S.V. Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications. Am. J. Physiol. Cell Physiol., 2010, 299(5), C1212-1219.